Serum monocyte chemotactic protein-1 concentrations distinguish patients with ankylosing spondylitis from patients with mechanical low back pain

Journal of Spinal Disorders and Techniques

Volumn 24, Issue 3, 2011, Pages 202-207

  Romero Sanchez, Consuelo ^a   Tsou, Hsi Kai ^b   Jan, Ming Shiou ^c   Wong, Ruey Hong ^d   Chang, I Chang ^e   Londoño, John ^a   Valle Oñate, Rafael ^a   Siew Howe, Hwee ^f   Yu, David ^g   Leung, Bernard P ^h   Wei, James Cheng Chung ^d,i  

^a UNIVERSIDAD DE LA SABANA   (Colombia)

^b FENG CHIA UNIVERSITY   (Taiwan)

^c Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAN TOCK SENG HOSPITAL   (Singapore)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ NONE   (Taiwan)

Author keywords

Ankylosing spondylitis; cytokines; low back pain; monocyte chemotactic protein 1

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1 BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LOW BACK PAIN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING TEST; SYNOVIAL FLUID LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 79955599181     PISSN: 15360652     EISSN: None     Source Type: Journal    
DOI: 10.1097/BSD.0b013e3181e15cc8     Document Type: Article

References (20)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379-1390. (Pubitemid 46590387)
2. Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol. 1995;34:1074-1077. (Pubitemid 26013512)
3. Calin A, Porta J, Fries JF, et al. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-2614. (Pubitemid 8104225)
4. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54:569-578. (Pubitemid 43228633)
5. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum. 2005;52:1000-1008. (Pubitemid 40530105)
6. Rudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63:535-543. (Pubitemid 38530197)
7. Rudwaleit M, Feldtkeller E, Sieper J. Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis. 2006;65:1251-1252. (Pubitemid 44277412)
8. Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis. 2009;68:777-783.
9. Dougados M, Gueguen A, Nakache JP, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol. 1999;26:971-974. (Pubitemid 29195696)
10. Brown MA. Human leucocyte antigen-B27 and ankylosing spondylitis. Intern Med J. 2007;37:739-740. (Pubitemid 47512341)
11. Chen CH, Yu DT, Chou CT. Biomarkers in spondyloarthropathies. Adv Exp Med Biol. 2009;649:122-132.
12. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34: 1218-1227.
13. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-368. (Pubitemid 14134775)
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324. (Pubitemid 18091653)
15. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21: 2286-2291.
16. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994; 21:2281-2285.
17. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 1994;21:1694-1698. (Pubitemid 24285485)
18. Vroomen PC, de Krom MC, Wilmink JT, et al. Diagnostic value of history and physical examination in patients suspected of lumbosacral nerve root compression. J Neurol Neurosurg Psychiatry. 2002;72:630-634. (Pubitemid 34462818)
19. Gu J, Rihl M, Marker-Hermann E, et al. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol. 2002;29:2159-2164.
20. Rao G. What is an ROC curve? J Fam Pract. 2003;52:695. (Pubitemid 37412717)